HemaSphere
(Nov 2022)
High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis
- Elsemieke te Linde,
- Laura J. E. Boots,
- Laura G. M. Daenen,
- Moniek A. de Witte,
- Anke H. W. Bruns
Affiliations
- Elsemieke te Linde
- 1 Department of Infectious Diseases, University Medical Center Utrecht, the Netherlands
- Laura J. E. Boots
- 1 Department of Infectious Diseases, University Medical Center Utrecht, the Netherlands
- Laura G. M. Daenen
- 2 Department of Hematology, University Medical Center Utrecht, the Netherlands
- Moniek A. de Witte
- 2 Department of Hematology, University Medical Center Utrecht, the Netherlands
- Anke H. W. Bruns
- 1 Department of Infectious Diseases, University Medical Center Utrecht, the Netherlands
- DOI
-
https://doi.org/10.1097/hs9.0000000000000793
- Journal volume & issue
-
Vol. 6,
no. 11
p.
e793
WeChat QR code